Pfizer’s Maddaluna retiring as head of global supply after 41 years with the company

Anthony J. Maddaluna

Pfizer’s executive vice president and president of global supply, Anthony J. Maddaluna, is retiring from the pharma giant after more than 41 years with the company.

Maddaluna first started with Pfizer in 1975 and worked his way up the ranks, holding a number of key positions during his career. He was named president of global supply in 2011, the company said.

“I have had the privilege of working with Tony during much of his career, and he has been a valuable partner to me,” Ian Read, Pfizer’s chairman and chief executive officer, said in a statement. “Tony has continually demonstrated a steadfast commitment to Pfizer and our mission.”

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

Kirsten Lund-Jurgensen has been named to succeed Maddaluna, effective at the end of the year. She is currently vice president of innovative health product portfolio management and consumer operations.

Prior to joining Pfizer in 1999, Lund-Jurgensen was with SmithKline Beecham, where she held several positions with operational responsibilities.